Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis Susanna M. WallerstedtAstrid Nilsson EkBarbro Linderholm Review Open access 05 June 2020 Pages: 1199 - 1211
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib Christel C. L. M. BoonsLonneke TimmersJacqueline G. Hugtenburg Clinical Trial Open access 02 June 2020 Pages: 1213 - 1226
Establishment of reference intervals of biochemical analytes for healthy Chinese volunteers during the screening process in clinical pharmacology trials Ping ZhongHuanwen ChenJianfeng Liu Clinical Trial 03 June 2020 Pages: 1227 - 1235
First-in-human dose: current status review for better future perspectives Archana MishraSudhir Chandra SarangiKh Reeta Clinical Trial 03 June 2020 Pages: 1237 - 1243
A novel mechanism of ACE inhibition–associated enhanced platelet reactivity: disproof of the ARB-MI paradox? Carolin HeltenPhilipp MourikisAmin Polzin Pharmacodynamics 05 June 2020 Pages: 1245 - 1251
Effect of a rabeprazole half-dose twice daily on acid inhibition in patients with different CYP2C19 alleles Masaki MurataMitsushige Sugimoto Pharmacodynamics 02 June 2020 Pages: 1253 - 1261
Age-dependent association of CYP2C19 polymorphisms with clinical outcome of clopidogrel therapy in minor stroke patients with large-artery atherosclerosis Dapeng WangLingjie LiQi Fang Pharmacogenetics 05 June 2020 Pages: 1263 - 1271
Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma Greet Van De SijpeBenoit BeuselinckIsabel Spriet Pharmacokinetics and Disposition 30 May 2020 Pages: 1273 - 1280
External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients YL. WangR. GuilhaumouAmélie Marsot Pharmacokinetics and Disposition 04 June 2020 Pages: 1281 - 1289
Aggregation and analysis of indication-symptom relationships for drugs approved in the USA Ananth PunyalaRachana LankapalliRebecca Racz Pharmacoepidemiology and Prescription Open access 03 June 2020 Pages: 1291 - 1299
Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database Carlo PiccinniLetizia DondiNello Martini Pharmacoepidemiology and Prescription 28 May 2020 Pages: 1301 - 1310
Borrowing external information to improve Bayesian confidence propagation neural network Keisuke TadaKazushi MaruoMasahiko Gosho Pharmacoepidemiology and Prescription 01 June 2020 Pages: 1311 - 1319
Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study Jean-Louis MontastrucVanessa RousseauFrançois Montastruc Pharmacoepidemiology and Prescription 01 June 2020 Pages: 1321 - 1327
Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data Claudia BeckerMatthias SchwenkglenksChristoph R. Meier Pharmacoepidemiology and Prescription 06 June 2020 Pages: 1329 - 1335
Pharmacokinetics of imipenem in both plasma and peritoneal draining liquid in elder patients with perforated upper gastrointestinal tract Lingti KongJian XuLei Li Letter to the Editor 30 May 2020 Pages: 1337 - 1339
Leflunomide-induced recurrent-transient ischaemic attacks in a patient with rheumatoid arthritis: first case report Cristian Eduardo NavarroPilar Enríquez-RuanoMaira Nataly Enríquez-Ruano Letter to the Editor 28 May 2020 Pages: 1341 - 1342
No association between hydrochlorothiazide use and uveal melanoma Anton PottegårdSidsel Arnspang PedersenKasper Bruun Kristensen Letter to the Editor 03 June 2020 Pages: 1343 - 1344